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ABSTRACT 
Object:   
Patients with an intact hypothalamic pituitary adrenal (HPA) axis produce an 
intraoperative surge of serum cortisol during transsphenoidal pituitary surgery.  This 
surgery is considered appropriate that no further doses of steroids are required during and 
after surgery.  In this prospective study we tested the feasibility of withholding steroids 
during the perioperative period for patients undergoing transsphenoidal surgery for 
pituitary adenomas with a normal preoperative hypothalamic pituitary axis (HPA axis).  
 
Methods:  
 
A total of 105 patients undergoing transsphenoidal surgery for pituitary adenomas 
were assessed preoperatively.  Patients with an 8AM serum cortisol >16 mcg/dl were 
considered to have a normal HPA axis and for those with a cortisol<16 mcg/dl, a 
Synacthen test was done and if the cortisol levels rose to >20mcg/dl, they were 
considered to have a normal HPA axis.  Group 1 (61) patients who had a normal HPA 
axis underwent surgery without perioperative steroid cover.  Group 2 (44) patients 
received perioperative steroids because of hypocortisolism.   Group 1 patients were found 
to have smaller tumors as compared to Group 2 (p<0.001).  The 2 groups were similar 
with regard to the age, extent of excision and the incidence of intraoperative CSF leak.  
Group 1 patients who did not receive perioperative steroids were monitored 
postoperatively for hypocortisolism and results tabulated. 
 
 Results:   
 
In Group 1 the mean 8 AM cortisol levels before surgery and on the postoperative 
days 1, 2 & 3 were 14.3, 21.6, 14.5 and 13.1 mcg/dl respectively (fig 1).  The surge in 
cortisol value on Day 1 was significant (p=0.04).  In Group 1, 19 out of 61 patients 
required steroid supplementation.  Eleven of them were symptomatic and 2 patients had 
cortisol levels <5 mcg/dl but asymptomatic.  Sixteen patients had hyponatremia out of 
which 10 patients were symptomatic.  Eleven patients came for follow up after 3-6 
months; steroids were withdrawn in 5 and 6 required long term steroids.  The incidences 
of hyponatremia in both the groups were similar. There was a higher incidence of 
Diabetes Insipidus in Group 2, 9.09% vs. 3.27% in Group 1. 
 
Conclusions 
  After transsphenoidal pituitary surgery 21% of patients with preoperative normal 
HPA axis will still require steroids replacement. 
 
Key words        Pituitary adenomas             hyponatremia          diabetes insipidus 
 
 
  
AIMS AND OBJECTIVES 
 
1. To determine the postoperative cortisol levels in patients with pituitary adenomas 
undergoing transsphenoidal surgery without perioperative steroids. 
 
2. To determine the incidence of hypocortisolemia and other complications in patients with 
pituitary adenomas undergoing transsphenoidal surgery without perioperative steroids.  
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INTRODUCTION 
 
Transsphenoidal surgery for pituitary adenomas is the favoured approach for the surgical 
management of these tumors. Conventionally glucocorticoids are administered perioperatively to 
all patients undergoing transsphenoidal pituitary surgery under the presumption that there is a 
temporary dysfunction of the pituitary gland1 during surgery.  
 
Our experience is that it is possible to identify and preserve the normal adenohypophysis 
during transsphenoidal pituitary surgery.2  It is debatable whether perioperative steroid 
supplementation is required when the preoperative cortisol levels are normal.3, 4 ,5 It has been 
noticed that there is an intraoperative surge of serum cortisol levels in those patients with 
preoperative normal HPA axis, probably an appropriate response to the stress of surgery.6   
 
A prolonged postoperative course of steroids also might suppress the adrenal function that 
will masking a potential recovery of the HPA axis function making the postoperative assessment 
of the HPA axis difficult in those patients who receive supra-physiological doses of steroids.7  
Recently, trials have shown that reduction in the dose of postoperative steroid supplementation is 
safe and beneficial.2 
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In this study, we identified those patients with a normal pituitary adrenal axis from 
preoperative serum cortisol levels and a positive Synacthen test and withheld steroids for these 
patients perioperatively. These patients were monitored closely in the postoperative period both 
clinically and with daily serum cortisol estimations for 3 days and the HPA axis assessed again at 
3-6 months following the surgery. 
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 REVIEW OF LITERATURE 
 
The pituitary gland 
  
 The pituitary gland is located within the sella turcica and weighs 0.6 g. It is composed of an 
anterior adenohypophysial component and a morphologically, embryologically, and functionally 
distinct posterior neurohypophysial component. The pituitary gland is entirely ectodermal in 
origin. The adenohypophysis develops from the Rathke’s pouch by upward invagination and the 
neurohypophysis develops from the infundibulum by downward extension from the floor of the 
diencephalon (Fig 1 & 2).  
  
 The anterior adenohypophysis secretes the Follicle stimulating hormone (FSH), Leutinizing 
hormone (LH), Adrenocorticotrophic hormone (ACTH), Thyroid stimulating hormone (TSH), 
Prolactin and Growth hormone (GH). The neurohypophysis secretes Oxytocin which promotes 
uterine contractions and lactation and the anti-diuretic hormone (ADH). 
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 Fig.1 Location of the Pituitary gland 
 
 
 
 
 
 
 
 
 
Fig.2 Anatomical relationships of the pituitary gland  
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Pituitary adenomas-A brief overview 
  
 Pituitary tumors account for 10-15% of all brain tumors with the highest incidence between 
the 3rd-6th decades.  It is found to be more common in women than men with a genetic 
predisposition seen only in MEN syndrome.  
 
Prolactinoma account for nearly 30% of pituitary adenomas and are more commonly micro 
adenomas. They present with amenorrhea / galactorrhea. The serum prolactin levels are > 200 
ng/ml. The first line treatment is pharmacologic with drugs like Bromocriptine and Cabergoline. 
 
Growth hormone secreting tumors are most commonly macroadenomas occurring in the 4th 
and 5th decades. They present with coarse facial features, thickening of lips, enlargement of nose.  
The serum GH level is > 5 ng/ml with an elevated IGF-1 (Insulin like growth factor). Corticotroph 
secreting adenomas account for 8-10% of pituitary tumors. They produce a hypercortisolemic state 
generated in response to an ACTH-secreting pituitary tumor. They present with weight gain, 
truncal obesity, buffalo hump.  Biochemically there is no cortisol suppression on low-dose 
dexamethasone testing, cortisol suppression on high-dose dexamethasone testing, and moderately 
elevated ACTH levels.  
 
  
 
 
 11
Thyrotroph adenomas form less than 1% of pituitary adenomas and manifest with signs of 
hyperthyroidism. They have a high TSH with high free T4. Clinically silent pituitary tumors 
account for 1/4th of pituitary tumors. They usually present due to mass effect on the optic chiasm 
or hypopituitarism. 
 
Anatomical classification of pituitary adenomas 
  
WHO classification includes a five tiered classification as 
1) Clinical presentation and secretory activity 
2) Size and invasiveness (e.g. Hardy) 
3) Histology (typical vs. atypical) 
4) Immunohistologic profile 
5) Ultrastructural types 
 
We will need to know the anatomical classification which gives information regarding the 
size and invasiveness of the tumor. 
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Hardy’s classification of tumor (size and invasiveness) 
 
Type A-Tumor with suprasellar extension not reaching the optic chiasm 
Type B-Tumor reaches the floor of the 3rd ventricle, obliterating the anterior recess of the third 
ventricle without indenting it. 
Type C-Tumor indents the floor of the third ventricle. 
Type D-Tumor with intradural extension 
Type E- Tumor invading the cavernous sinus 
 
Knosp Classification of parasellar extension of tumor (Fig.3)24 
 
Grade 0: The adenoma did not encroach the cavernous sinus space; not crossing the medial aspect 
of intra and supracavernous ICA. 
Grade 1: The tumor crossed the medial tangent but does not extend beyond the intercarotid line. 
Grade 2: The tumor crossed beyond the intercarotid line but does not cross beyond the lateral 
tangent of intra and supra cavernous ICA. 
Grade 3: The tumor crossed beyond the lateral tangent of intra and supracavernous ICA 
Grade 4: There was total encasement of the intracavernous carotid by the tumor.  
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Fig 3: Knosp classification of cavernous sinus invasion24 
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Hypothalamo pituitary adrenal axis(HPA) 
 
The main components of the HPA axis are the para-ventricular nucleus of the 
hypothalamus which contains neuro-endocrine neurons that synthesize and secrete vasopressin and 
corticotropin-releasing hormone (CRH)(Fig 4).  The corticotrophin releasing hormone and 
vasopressin both stimulate the secretion of adrenocorticotropic hormone (ACTH).  ACTH in turn 
acts on the adrenal cortices, which produce the glucocorticoid hormones.  The glucocorticoids in 
turn act on the hypothalamus and pituitary (to suppress CRH and ACTH production) in a negative 
feedback cycle.8, 9  
 
 Hence in a patient with a pituitary adenoma, there is dysfunction at the level of the 
pituitary gland with a decreased secretion of the ACTH and a low serum cortisol due to a 
decreased release from the adrenal gland.  In some patients, the adrenal reserve of cortisol is still 
maintained responding to exogenous ACTH. This is done in a Synacthen test which involves 
administration of synthetic ACTH intravenously and the serum cortisol assessed one hour later. 
This test can be done at anytime during the day and helps to identify patients who can still manage 
to produce an appropriate surge of cortisol during surgery. 
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 Fig 4: The Hypothalamo pituitary axis (HPA)  
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The circadian rhythm 
Release of CRH from the hypothalamus is influenced by stress, blood levels of cortisol and 
by the sleep/wake cycle.  The human sleep and wake cycles are generated by a complex interaction 
of the circadian and sleep processes. The main purpose of the circadian rhythm is to produce 
wakefulness during the day and conserve sleep for the night. 
 
The suprachiasmatic nucleus (SCN) in the anterior hypothalamus is the central pacemaker 
for circadian rhythms and is synchronized with the external environment. Looking at the molecular 
level, the circadian clock gene proteins oscillate in an autoregulatory feedback and generate a self 
sustained regulated over a period of  24 hours.10-13 
 
In healthy individuals, serum cortisol rises rapidly after waking up, reaching a peak within 
30–45 minutes (Fig 5). It then gradually falls over the day, rises again in late afternoon. Cortisol 
levels then fall in late evening, reaching a trough during the middle of the night. 8,  9, 14.  
This corresponds to a decrease in alertness during the midday at around 2–4 p.m and an 
increase in alertness peaking at the early to mid-evening hours subsequently falling by 4–6 a.m.  In 
the early evening hours, there is an increased homeostatic drive for sleep when the circadian 
alternating signal is also high.14-17  
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 Anatomical connections between brain areas such as the amygdala, hippocampus, and 
hypothalamus facilitate activation of the HPA axis. Increased production of cortisol mediates 
alarm reactions to stress, facilitating an adaptive phase of a general adaptation syndrome in which 
alarm reactions including the immune response are suppressed, allowing the body to attempt 
counter measures. 
Fig 5: The circadian rhythm of serum cortisol 
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 Assessment of the HPA axis  
The Insulin tolerance test was considered the gold standard15 to assess the HPA axis but the 
Synacthen test has become popular as it can be done easily on an outpatient basis and is equally 
reliable.16, 17  The insulin tolerance test carries a risk of hypoglycemia and requires inpatient 
observation for the same.  It also requires an assessment of the renal function.  Though it remains 
the gold standard to assess the HPA axis, the short Synacthen test is preferred in view of 
convenience.18, 19 
There are two doses of Synacthen, 250mcg and 1 mcg (low dose), each supported by 
literature18-21. However the 250 mcg dose Synacthen test is preferred because it considered close to 
accurate with the Insulin tolerance test.  
 The Synacthen test involves administration of 1ml (250 mcg) of synthetic ACTH 
intravenously and measuring serum cortisol level one hour following the injection. If the serum 
cortisol levels rise greater than 20 mcg/dl (Fig 6), these patients are considered to have normal 
HPA axis.22  Earlier the authors used a cut off of 18 mcg/dl but subsequently raised it to 20 mcg/dl 
after a study in 1998 (unpublished observation by Inder et al) which showed that many people with 
cortisol levels post synacthen test between 18-20 mcg/dl still had ACTH deficiency.  Hence the cut 
off was raised though there was a chance of falsely grouping patients with normal HPA axis as 
with ACTH deficiency. 
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  In a study including 72 patients undergoing transsphenoidal resection of non-functioning 
pituitary adenomas by Cozzi et al, 14 patients (19.4%) had hypocortisolemia pre-operatively as 
defined by an 8am serum cortisol level less than 8 mcg/dl and they were given perioperative 
steroids.23  Since a definitive test such as Synacthen or an Insulin tolerance test was not done 
preoperatively in this study the incidence of preoperative hypocortisolemia might have been 
underestimated. Hence the requirement of a standard test to identify patients with a normal HPA 
axis is required. In one of the studies by Oelkers et al19, 13 out of 57 (22.8%)  patients had an 
abnormal response to the short Synacthen test and 14 of 57(24.56%) patients had an abnormal 
response using the Insulin hypoglycaemia test.  
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 Fig 6: Assessment of HPA axis based on Synacthen test 
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Factors causing preoperative hypocortisolemia 
 
Tumor-related depletion of pituitary function causing steroid insufficiency  occurs either 
due to destruction of the normal gland or due to hypothalamic disease. There is predominantly 
destruction of the anterior pituitary causing a deficiency in some or all pituitary hormones.24  The 
size of the adenoma is found to influence the occurrence of hypocortisolemia/ hypo-pituitarism in 
the pre and postoperative period. Large tumors (Hardy’s C, D, E tumors) are more likely to 
compress the normal gland and cause dysfunction of the gland. A macroadenoma (>10 mm) was 
found more likely to compromise normal pituitary function resulting in secondary adrenal 
insufficiency.24 
Pituitary apoplexy causes sudden destruction of the normal pituitary tissue due to infarction 
or hemorrhage into the pituitary. Apoplexy usually spares the posterior pituitary and solely affects 
the anterior pituitary.24 
The surgical approach, transsphenoidal or trans-cranial will influence the postoperative 
requirement of steroid administration because we administer preoperative steroids in transcranial 
surgeries to reduce cerebral oedema.  In patients who undergo a transsphenoidal resection in our 
setting postoperative steroid cover is tapered rapidly over 2 to 3 days to physiologic replacement or 
discontinued if postoperative serum cortisol levels are normal after stopping hydrocortisone.   
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  The safe level of serum cortisol on postoperative days 1,2 and 3 following surgery for 
patients in whom steroids were withheld have been analysed and a guideline has been put forward 
in the study by Inder et al22  and it has been found safe to withhold steroids in patients with an 8 
AM serum cortisol > 16 mcg/dl. In patients with a serum cortisol between 9-16 mcg/dl it is safe if 
the patient is asymptomatic and no hyponatremia. With cortisol between 3.6- 9 mcg/dl, a definitive 
test can be done and steroids given only during periods of stress. Definite steroid replacement 
needs to be given if 8 AM cortisol levels were below 3.6 mcg/dl. This cut off of 3.6 mcg/dl which 
defines definitive hypocortisolemia is based on the guidelines laid down by Inder et al.22 
  
In a study by Zada et al27, the cortisol index was calculated retrospectively for assessment 
of the cortisol stress response following transsphenoidal pituitary surgeries in 52 patients. Cortisol 
index was estimated from the difference between the postoperative Day 1 8am cortisol and the 
preoperative basal cortisol.   It was seen in that study that there was a significant difference 
(p<0.005) between the mean cortisol index in patients who required perioperative steroids (-
2.8mcg/dl) and mean cortisol index in patients who did not receive steroids (+14.4mcg/dl).   From 
the mean cortisol index, he found that there was an 87% increase in cortisol in the immediate 
postoperative period. This implies an appropriate cortisol surge during surgery in all these patients. 
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 The postoperative assessment of the HPA axis becomes crucial since the surgeon may not 
have preserved the adenohypophysis and it needs to be determined whether the patient requires 
steroids till follow up. 
 
In patients who have received perioperative steroids the postoperative assessment 
performed  on days 7-14 have a good predictive value of the requirement of long term 
glucocorticoid replacement28, 29.  Another alternative is to do the definitive test at 4-6 weeks follow 
up which will offer an advantage to identify patients with a late recovery of the HPA axis 
postoperatively29.  
 
Insulin tolerance test is the preferred test and the next alternative is the Metapyrone test. 
But Synacthen test remains the convenient test practiced in most centres. 
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 Factors determining requirement of perioperative steroid cover 
 
 After analyzing the preoperative factors which could cause a hypocortisolemia, the main 
factor  that predict the normalcy of HPA axis postoperatively is the intraoperative preservation of 
normal gland tissue.  An increased surgical experience in transsphenoidal pituitary surgeries would 
increase the preservation of normal gland which would influence postoperative hypocortisolemia 
as found by Barker et al.25   
   
 If the normal gland is preserved by the surgeon, it may be possible to withhold steroids in 
patients with a preoperative normal HPA axis.   This is supported by studies2 which show that 
normal gland is usually compressed to the periphery of the tumor and an intracapsular dissection 
might help preserve normal gland during surgery. Though extra capsular dissection offers a better 
surgical cure, normal gland is preserved with intracapsular dissection.  
                                                                               
 
Are perioperative steroids required?   
 
The conventional protocol has been to administer high dose steroid cover in the 
perioperative period for patients undergoing transsphenoidal resection of pituitary adenomas. 1 
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 This is under the presumption that there is a temporary dysfunction of the pituitary gland1 
during surgery. Our experience is that it is possible to identify and preserve the normal 
adenohypophysis during transsphenoidal pituitary surgery.2  It is debatable whether perioperative 
steroid supplementation is required when the preoperative cortisol levels are normal.3, 4,  5  It has 
been noticed that there is an intraoperative surge of serum cortisol levels in those patients with 
preoperative normal HPA axis, probably an appropriate response to the stress of surgery.6  
 
 A prolonged postoperative course of steroids also might suppress the adrenal function that 
will mask patients who can have a potential recovery of the HPA axis function. Also the 
postoperative assessment of the HPA axis becomes difficult in those patients who receive supra-
physiological doses of steroids, as their endogenous steroid secretion is suppressed7.   
 
Udelsman et al26 had earlier proved that supra-physiological doses of steroids did not offer 
any significant advantage during the surgical stress in adrenalectomised primates.  Patients who 
had been taking at least 7.5 mg prednisolone daily for several months and had secondary adrenal 
insufficiency as defined by adrenocorticotropic hormone testing formed the study population.  
Patients were randomized to two groups. One group received perioperative injections of saline 
solution alone and included 12 patients; the other received perioperative saline solution and 
cortisol and included 6 patients.  All patients received their usual daily prednisolone dose 
throughout the study.  Two patients one in each group developed hypotension, which got corrected 
with volume replacements. None of them required additional doses of steroids than their usual 
doses in the perioperative period. 
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 Rajaratnam et al5 also supported the fact that no supraphysiological doses of steroids were 
required in their study wherein they studied 16 patients  prospectively with Hardy’s A and B 
tumors in whom perioperative steroids were withheld and only one patient required steroid cover 
because it was a second stage surgery.  
 
Hence we can safely withhold steroids in patients identified to have a normal preoperative 
HPA axis using a definitive test.   
 
 
Immediate postoperative HPA axis and long term glucocorticoid replacement 
 
The immediate postoperative normal cortisol levels were found to predict the normalcy of 
the HPA axis in the long term. In a study by Nicholas et al29, 100 patients with normal preoperative 
HPA axis as assessed by Cortosyn stimulation test (CST) underwent 104 transsphenoidal/ trans-
nasal pituitary adenoma surgical resections and steroids were withheld perioperatively.  
Postoperatively, HPA axis assessed as normal by CST  4-6 weeks later  remained the same at 4-6 
months follow up.  He showed that a normal preoperative HPA axis was able to identify patients 
who will have normal HPA axis function after transsphenoidal pituitary surgery. The ability of 
immediate postoperative cortisol levels >15 mcg/dl (done 60-80 minutes after the surgery) to 
predict normal HPA axis function in future was assessed by standard analytical methods with a 
sensitivity of 98% and a positive predictive value of 99%. 
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Steroids and postoperative Diabetes insipidus 
 
 Diabetes insipidus has been a common side effect noticed in the postoperative period 
following transsphenoidal pituitary surgeries.  The incidence of transient diabetes insipidus is 
higher about 10-66% and the permanent DI around 0.4 –15%. 30-34 Diabetes Insipidus increases the 
postoperative morbidity and duration of hospital stay.  
   
 
  A pituitary adenoma, regardless of the size, rarely causes diabetes insipidus (DI) before 
surgical intervention.34 Steroids are found to suppress the release of anti diuretic hormone (ADH) 
produced in the pituitary gland. This is because ADH is also known to act as a corticotrophin 
releasing factor on the pituitary gland.34  Hence when there is exogenous steroid administration, 
they suppress the release of ADH and cause diabetes insipidus. This is known to unmask the 
incidence of diabetes insipidus in patients undergoing trans-sphenoidal pituitary adenoma 
resections.  Steroids also increase the threshold of serum osmolarity required for the release of 
vasopressin.   
 
 
  In the study by Rajaratnam et al5, 114 patients were randomized into 3 groups one 
day before surgery, 32 patients in the conventional high dose steroid regimen, 30 in the 
intermediate dose regimen and 52 patients in the low dose regimen.  It was noticed that there was a 
reduction of the incidence in DI to 46% in group 3, the low dose regimen (p=0.025). It was also 
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noticed that the patients in group 3 did not require change over to the high or intermediate dose 
regimen anytime.  Steroid deficiency was associated with an increased synthesis of vasopressin. 
This is known to occur in high doses of steroids and the incidence is less with low doses of 
postoperative steroid supplementation. 
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  MATERIALS AND METHODS 
 
Patient population 
This was a prospective study that included 105 patients who underwent transsphenoidal 
surgery for pituitary adenomas between June 2010-December 2012 with age <60 years. The HPA 
axis before surgery was assessed based on the protocol as laid down in the guidelines for 
perioperative steroid replacement by Inder et al22.(Fig 7) Patients with 8 am serum cortisol greater 
than 16 mcg/dl were considered to have a normal HPA axis and did not receive steroid cover 
during surgery.  All patients with preoperative cortisol levels less than 3.6 mcg/dl were covered 
with steroids that were continued till follow-up. Patients with a serum cortisol between 3.6-16 
mcg/dl underwent a Synacthen test and were not given perioperative steroid cover if their HPA 
axis was normal as determined by this test. 
 
The Synacthen test 
Patients with 8 am serum cortisol between 3.6-16 mcg/dl underwent a Synacthen test to 
assess the adequacy of the HPA axis.  The Synacthen test involved administration of 1ml (250 
mcg) of synthetic ACTH intravenously and serum cortisol was measured one hour following the 
injection. If the serum cortisol levels increased to greater than 20 mcg/dl, these patients were 
considered to have a normal HPA axis 14 and did not receive steroid cover during surgery.  
If the serum cortisol level was <20 mcg/dl the HPA axis was considered to be abnormal 
and the patient received perioperative steroids.   
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Fig. 7 Assessment of the preoperative HPA axis based on the 8 AM serum cortisol and 
Synacthen test - an algorithm 
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Fig. 8 Synacthen Ampoule: 
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Fig 9: Chemical Structure of ACTH (Adreno Corticotropic Hormone) 
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 Groups 1 & 2 
 
The 105 patients were divided into 2 groups (Table 1) based on the preoperative evaluation. 
Group 1 included the 61 patients with a preoperative normal HPA axis and did not receive 
perioperative steroid cover. Group 2 included 44 patients with abnormal HPA axis and those 
already on preoperative steroids.  Group 2 patients received Inj.Hydrocortisone 25 mg 6thhrly on 
day one, followed by oral prednisolone 10 -0-5 mg on day two, 5-0-2.5 mg on day three and 
stopped. Steroids were continued further postoperatively only if the patients were already on 
steroids preoperatively or their postoperative cortisol levels were below 5 mcg/dl on any of the 
three days following surgery. 
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Table 1 Inclusion criteria for Group 1 and Group 2 
 
 
 
Group1 (61 patients ) Group 2 (44 patients) 
Normal HPA axis Already on steroids 
No perioperative steroids Abnormal HPA axis 
- Received perioperative steroids (IV 
steroid for 24 hrs & oral steroids for the 
next 48 hours). 
- Steroids continued only if patient was on 
steroids prior to surgery / the post op 
cortisol levels were low (<5 µg/dl). 
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Postoperative follow up 
.   
If the surgeon was unable to recognize or preserve the adenohypophysis at surgery the 
patient was given steroid cover postoperatively irrespective of the preoperative integrity of the 
HPA axis.  
 
For the first 3 days after surgery, a serum 8AM cortisol and twice daily serum sodium 
estimations were done.  Postoperatively, the patients were monitored for symptoms of 
hypocortisolism in the ICU and ward such as nausea, vomiting and tiredness/lethargy. A random 
cortisol was done whenever hypocortisolism was clinically suspected. 
 
Injection hydrocortisone was given if any serum cortisol value was <3.6 mcg/dl. In addition 
those patients who complained of nausea, vomiting or tiredness had an immediate serum sodium 
and a cortisol sample drawn and Injection Hydrocortisone was given immediately. Subsequently if 
the cortisol levels were normal but the sodium value was < 130 mEq/L, the patient was treated as 
for hyponatremia without continuing steroids.  
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RESULTS AND ANALYSIS 
 
Multiple factors including age, gender and incidence of preoperative hypothyroidism, 
apoplexy and the size of tumor were compared between the 2 groups (Table 2). The postoperative 
factors including the extent of excision, postoperative CSF leak, incidence of diabetes insipidus 
and the hyponatremia were also compared (Table 2).  
 
Analysis of perioperative data between the 2 groups 
There was a significantly higher incidence of small tumors in Group 1 patients with normal 
HPA axis. There were 36 patients with small tumors in Group 1 as compared to 11 patients in 
Group 2 with a p value=0.001(Table 2).   
 
There was almost equal incidence of apoplexy in both the groups and there was no 
difference in functional status of the tumor. There was also no significant difference in the 
incidence of preoperative hypothyroidism between the 2 Groups and hence not found to influence 
the steroid requirement status preoperatively. There was no significant difference in the incidence 
of other factors as age or gender between the 2 Groups.  
 
Another interesting fact noticed was that there was a similar incidence of postoperative 
hyponatremia in Groups 1 and 2, 22.99% versus 20.45% respectively.  The incidence of  
postoperative  DI in patients in Group 1(3.27%) was less than that in Group 2 (9.09%).  Although 
the incidence of DI was higher in Group 2 (3.27% versus 9.09%) this was not statistically 
significant. 
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 Table 2: Comparison of pre and intraoperative factors in Groups 1 and 2 
 
 Group 1 (N=61) Group 2 (N= 44) P Value 
Age (mean / SD) 40 / 10.92 40 / 12.30 0.1 
Gender Male (No:/%) 28/46 28/64  
Hypothyroidism 
(No:/%) 
8 / 13 10 / 23  
Apoplexy (No:/%) 10/16. 7/16  
Type of adenoma 
          GH (No: / %) 
           Non-functional 
 
36 / 59 
25 / 41 
 
15 / 34 
29 / 66 
 
Size of adenoma 
         Hardy A 
                     B 
                     C 
                     D 
             Invasive 
                  Micro    
 
12 / 20% 
18 / 30% 
22 / 36% 
  1 / 2% 
  2 / 3% 
  6 / 10% 
 
 1 / 2% 
 9 / 20% 
25 / 57% 
 3 / 7% 
 5 / 11% 
 1 / 2% 
 
0.001 -  Small tumors 
<0.001 - Large tumors 
 
Radical excision 34 / 56 % 19 / 43% 0.23 
 
Subtotal / Partial 
Excision 
26 / 43%  25 / 57% 0.17 
 
Intra-operative CSF 
leak 
26 / 43% 17 / 39% 0.69 
 
Gland not preserved 0 15 / 34% 0.0001 
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 Table 3: Comparison of the postoperative complication factors in Group 1 and Group2 
 
 Group 1 Group 2 P Value 
Symptoms of hypocortisolemia 11 / 18% - 0.0001 
Hyponatremia 16 / 23% 9 / 20% 0.64 
 
Post-operative diabetes insipidus 2 / 3% 4 / 9% 0.40 
 
 
Postoperative serum cortisol levels in Group 1 
 
The mean serum cortisol levels in Group 1 preoperatively and on the postoperative days 1,2 
and 3 as well as at follow up are shown in Figure 11.  The mean preoperative 8am serum cortisol 
value was 14.77 mcg/dl with a standard deviation (SD) of 6.72. The mean / SD values for the 
postoperative cortisol levels on days 1,2 and 3 for all the 61 patients were 23.00 / 13.79, 15.68 / 
16.38 and 14.96 / 7.32 mcg/dl respectively. It was found there was significant difference between 
the mean preoperative cortisol and mean cortisol on day 1 (p=0.04) suggesting a definite cortisol 
surge in the immediate postoperative period by 55.7%  compared to the preoperative cortisol. The 
maximum surge of cortisol noticed among the 61 patients was 111%. 
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 Complications in the postoperative period 
 
Among the 61 patients in whom steroids were withheld, 42 patients(69%) did not have any 
problem postoperatively and their cortisol levels also remained normal during the first 3 days and 
were followed up after 3-6 months without steroids. The remaining 19 patients(31%) required 
steroids, 16 of them developed hyponatremia and hence were given steroids. Of the remaining 3 
patients, two had a low serum cortisol level, one with a cortisol value 1.88 mcg/dl on day 1 and 
another with a cortisol value 1.36 mcg/dl on day 2 after surgery and hence were given steroids. 
One patient developed generalized tiredness and vomiting on Day 3 after surgery with a cortisol 
level of 9.02 mcg/dl and had no hyponatremia and was given steroids. The mean serum cortisol 
value for the 16 patients who developed hyponatremia(Fig 14) were 19.84, 12.36 and 9.20 mcg/dl 
respectively on days 1,2 and 3. 10 of  16 patients had a serum cortisol less < 16 mcg/dl on the day 
steroids were administered for hyponatremia. Of the 19 patients who required steroids, 16 patients 
had hyponatremia of which 10 patients only were symptomatic. 5 patients had a serum cortisol< 
3.6 mcg/dl considered as definite hypocortisolemia of which 3 patients only were symptomatic.  
This accounts for the overlap of the number of patients described as a bar graph in Fig 14. 
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Fig. 10 Algorithm showing postoperative requirement of steroids in Group 1 and the 
reason and day of administration of steroids. 
 
 
 
 
 
61 patients 
42 (no steroids) 
16 (hyponatremia) 
    Day 3 - 1 
    Day 5 - 5 
    Day 7  -  6 
    Days 7-11  -  4 
3 pts 
19 (steroids given)  
 
 
 
 
 
 
 2 had Cortisol level 
< 3.6mcg/dl /  
Asymptomatic 
1 had symptoms 
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Fig.11 Shows the trends in the mean serum cortisol before surgery, on days 1,2 and 3 following 
surgery and at 3-6 months follow up for 61 patients in Group 1. It was seen that there was a 
definite surge in serum cortisol on Day 1 after  surgery suggesting a normal intraoperative 
surge. 
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Fig 12: The mean cotisol levels on Days1,2  and 3 compare between the patients who 
required and did not require steroids in Group 1 
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Factors determining steroid requirement in Group 1 (Table 4) 
 
The data from the 61 patients were analyzed for factors that could predict steroid 
requirement postoperatively (Table 4 ). There was no significant difference in the preoperative 
hypothyroidism, apoplexy nor the intraoperative CSF leak. There was a higher incidence of 
smaller tumors with in the 42 patients who did not require steroids. (p=0.09)  
 
The requirement of Synacthen test influencing the requirement of perioperative steroid 
cover were also analysed and among the 61 patients it was found that 11 of 19(58%) patients who 
required steroids and 26 of 42(62%) patients who did not require steroids were identified to have a 
normal HPA axis preoperatively based on the Synacthen test with no significant difference 
between them. It was also noticed that there was a significantly (p=0.001)higher instance of radical 
tumor excision in the 19 patients who required steroids(100%) versus that in the remaining 42 
patients who did not require steroids(55%)  which could suggest possibility of a decreased 
percentage of normal gland preservation during surgery.  
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Table 4: Comparison of the preoperative and postoperative factors within Group 1 between the 
19  patients who required steroids and the 42 patients who did not require steroids  
 
 Steroids given 
(19 patients) 
Steroids not given 
(42 patients) 
P Value 
Gender-males 8 19 1.00 
Apoplexy 2 8 0.47 
Preoperative 
hypothyroidism 
5 3 0.0941 
Synacthen test 11 26 0.78 
Small 
tumors(Microadenomas) 
8 (3) 28 (4) 0.094 
Intraoperative CSF leak 8 11 0.24 
Radical excision 19 23 0.0001 
Gland preserved 19 40 0.52 
Postoperative Diabetes 
insipidus 
1 1 0.06 
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Fig. 13 Demonstrates on a graph the number of patients who required steroids in the immediate 
postoperative period and the status of the 19 patients at 3-6 months follow up.  
8 patients were lost to follow up and steroids could be stopped for 5 patients and 6 required to be 
continued on steroids. 
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Fig 14 Shows the reasons why hydrocortisone was administered in the 19 patients. Sixteen patients 
developed hyponatremia of which 11 were symptomatic. Out of the 19 patients, only 5 patients had 
a low serum cortisol<3.6 mcg/dl. There was an overlap of the incidence of symptoms and 
hyponatremia among the 19 patients. 
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Outcomes at 3-6 months follow up in Group 1(Fig 13) 
 
All these 61 patients were followed up between 3-6 months after surgery.  All the 42 
patients who did not require perioperative steroids remained asymptomatic with normal serum 
cortisol level and did not require long term steroids. Of the 19 patients who were discharged on 
steroids, 6 required long term steroids at follow up. Steroids could be withdrawn in 5 of these 
patients as their serum cortisol level was normal. Eight patients were lost to follow-up. 
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                                                                   DISCUSSION 
 
 
Factors associated with preoperative hypocortisolemia 
 
We had analysed the following factors as size of tumor, hypothyroidism, apoplexy, age of 
the patient and type of tumor and studied the correlation with the incidence of preoperative 
hypocortisolism.   
 
In our study, there was a significant difference in the incidence of small tumor 
(microadenomas and Hardy’s A and B) versus large tumors (Hardy’s C, D and invasive adenomas 
within group 1 (p=0.001) and group 2 (<0.001)  axis. There was also significant difference noted 
between the incidence of small tumors in groups 1 (36) versus group 2 (11) , p=0.001. and also for 
large tumors in group 1 (25) versus group 2 (33) respectively (p<0.001) (Table 1). 
 
Other authors have also found that the size of the adenoma influences the occurrence of 
hypocortisolemia/ hypo-pituitarism in the pre and postoperative period. A macro adenoma (>10 
mm) was found more likely to compromise normal pituitary function resulting in secondary 
adrenal insufficiency. 36 
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Pituitary apoplexy causes sudden destruction of the normal pituitary tissue due to infarction 
or hemorrhage into the pituitary. Apoplexy usually spares the posterior pituitary and solely affects 
the anterior pituitary. 37  We found no significant difference in the incidence of apoplexy among 
Group 1 patients who required postoperative steroids and who did not require steroids (Table 7). 
 
Our evidence of preoperative hypopituitarism was based on a normal 8AM serum cortisol 
level.  24 patients had a normal cortisol level > 16 mcg/dl.  52 patients had a cortisol level <16 
mcg/dl and underwent the Synacthen test.  37 of them passed with a serum cortisol >20mcg/dl and 
15 patients failed. This is important because mere documentation of a random cortisol level < 16 
mcg/dl does not necessarily indicate hypocortisolemia since 37 out of 52(71%) patients passed the 
Synacthen test.  The incidence of preoperative hypocortisolism in our study was 19%. 
 
In a study by Cozzi et al including 72 patients undergoing transsphenoidal resection of non-
functioning pituitary adenomas, 14 patients (19.4%) had hypocortisolemia pre-operatively as 
defined by an 8am serum cortisol level less than 8 mcg/dl and they were given perioperative 
steroids.23  Since a definitive test such as Synacthen or an Insulin tolerance test was not done 
preoperatively in this study the incidence of preoperative hypocortisolemia might have been 
underestimated. Hence the requirement of a standard test to identify patients with a normal HPA 
axis is required. In one of the studies by Oelkers et al19, 13 out of 57 (22.8%)  patients had an 
abnormal response to the short Synacthen test and 14 of 57(24.56%) patients had an abnormal 
response using the Insulin hypoglycaemia test.  
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 Assessment of immediate postoperative cortisol response 
 
The conventional protocol has been to administer high dose steroid cover in the 
perioperative period for patients undergoing transsphenoidal resection of pituitary adenomas. 1  
Udelsman et al26 had earlier proved that supra-physiological doses of steroids did not offer any 
significant advantage during the surgical stress in adrenalectomised primates.   
 
In a study by Nicholas et al29   it was shown that a normal immediate postoperative HPA 
axis would be able to identify patients who will have normal HPA axis function at follow up later. 
The ability of immediate postoperative cortisol levels >15 mcg/dl (done 60-80 minutes after the 
surgery) to predict normal HPA axis function in future was assessed by standard analytical 
methods with a sensitivity of 98% and a positive predictive value of 99%. 
 
In another study, the cortisol level cortisol level on the morning after surgery in 83 patients 
undergoing transsphenoidal resection of pituitary adenomas were done and demonstrated that 
levels ≥ 15 μg/dl are predictive of normal long-term HPA function assessed by a definitive test 
done 1-3 months later with a sensitivity of 80.5%, specificity of 66.7% and a positive predictive 
value of 96.9%35. 
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In a study by Zada et al27, the cortisol index was calculated retrospectively for assessment 
of the cortisol stress response following transsphenoidal pituitary surgeries in 52 patients. Cortisol 
index was estimated from the difference between the postoperative day 1 8am cortisol and the 
preoperative basal cortisol.   It was seen in the study that there was a significant difference 
(p<0.005) between the mean cortisol index in patients who required perioperative steroids (-
2.8mcg/dl) and mean cortisol index in patients who did not require steroids (+14.4mcg/dl).   From 
the mean cortisol index, he found that there was an 87% increase in cortisol in the immediate 
postoperative period in those who did require steroids as compared to the 56% postoperative surge 
on Day 1 in our study. This implies an appropriate cortisol surge during surgery in all these 
patients. 
 
The safe level of serum cortisol on postoperative days 1,2 and 3 following surgery for 
patients in whom steroids were withheld have been analysed and a guideline has been put forward 
in the study by Inder et al22  and it has been found safe to withhold steroids in patients with an 8 
AM serum cortisol > 16 mcg/dl on the days 1,2 and 3. In patients with a serum cortisol between 9-
16 mcg/dl it is safe if the patient is asymptomatic and no hyponatremia. With cortisol between 3.6- 
9 mcg/dl, a definitive test can be done and steroids given only during periods of stress. Definite 
steroid replacement needs to be given if 8 AM cortisol levels were below 3.6 mcg/dl. 
  
In our study, the patients in whom steroids were withheld were monitored using a serum 
8AM cortisol and for hyponatremia and clinical deterioration. There are studies supporting the use 
of serum cortisol in the immediate postoperative period as a predictor of HPA axis in the long 
term. 
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 Our findings indicate that 42 out of the 61(69%) patients in whom steroids were withheld 
perioperatively did not have any problems postoperatively and subsequently at follow up. 
 
Nineteen patients required perioperative steroids either due to clinical symptoms,11 
patients (58%), hyponatremia, 16 patients (84%) or a serum cortisol<3.6 mcg/dl, 5 patients (26%). 
(Appendix 2). 
 
Five of the 19 patients had definite hypocortisolemia with a cortisol < 3.6 mcg/dl  of which 
3 developed symptoms and 2 were asymptomatic. 8 other patients had a serum cortisol < 16 
mcg/dl but > 3.6 mcg/dl of which 5 patients were symptomatic and also had hyponatremia, 2 had 
hyponatremia alone and one patient had become symptomatic but no hyponatremia.   The 2 
patients who had a low serum cortisol alone < 3.6 mcg/dl had their tumor size 2cm and 5 cm 
respectively.  Hence the incidence of true hypocortisolemia would include the 5 patients who had a 
serum cortisol level < 3.6mcg/dl and also the 8 patients who had either developed hyponatremia or 
clinical features of hypocortisolism with a serum cortisol< 16 mcg/dl. This would amount to a true 
incidence of 13 patients(21%).  Hence the possibilities considered for the hypocortisolemia in 
these patients postoperatively could be either inadequate preservation of the adenohypophysis or 
an infarction of the gland postoperatively. The remaining 6 of the 19 patients who had 
hyponatremia with or without symptoms were able to produce a good cortisol response> 16 mcg/dl 
and might have benefitted from an evaluation for other causes of hyponatremia as SIADH or a 
cerebral salt wasting syndrome. 
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16 patients developed hyponatremia of which 10 patients had a serum cortisol level < 16 
mcg/dl on postoperative days as described in Fig 10. The cortisol index for Day 1 was calculated 
for these 10 patients and it was also noticed that  6 patients had a postoperative surge of cortisol on 
day 1 after surgery and the remaining 4 patients had a drop in the serum cortisol with a negative 
cortisol index. (Appendix 2).  It was observed that the mean cortisol index was 6.5 mcg/dl for 
these 10 patients. This as compared to the study by Zada et al27 where the mean cortisol index 
estimated retrospectively for the patients who required steroids which was -2.8 mcg/dl suggesting 
that the actual number of patients who required steroids might have been lower than this group of 
19 patients who were required steroids. 
 
It was also noticed in our study that of the 16 patients who developed hyponatremia, 10 
patients developed a delayed hyponatremia (which is on day 7 or later) indicating that even though 
the immediate postoperative cortisols were normal on days 1,2 and 3, a delayed hypocortisolemia 
could still occur. The causes considered for this could be an infarcting residual adenohypophysis or 
an insufficient preservation of the adenohypophysis. But other causes of delayed hyponatremia 
need to consider too as SIADH and CSW since the first three days postoperatively were 
uneventful. 
 
All these 19 patients were continued on steroids at discharge for benefit of doubt. At a 
follow up 3-6 months after surgery  of these 19 patients who required steroids in the immediate 
postoperative period, 5 patients became off steroids at 3-6 months follow up while 6 patients were 
continued on steroids and 8 lost follow up. This might suggest the possibility of either a transient 
postoperative hypocortisolemia or a possibility of an SIADH/Cerebral salt wasting syndrome.  
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 Hyponatremia in the postoperative period 
 
The incidence of hyponatremia in the Groups 1 and 2 were 22.9% and 20.45% respectively.  
This almost equal incidence of hyponatremia in the 2 Groups suggests that withholding steroids 
might not be responsible for the hyponatremia and hence a detailed evaluation should be done to 
identify the appropriate management of postoperative hyponatremia to avoid over treatment with 
postoperative long term steroids. This puts down the fact that there were other causes of 
hyponatremia which need to be considered along with hypocortisolism. This also suggests a 
detailed evaluation to distinguish between syndrome of inappropriate antidiuretic hormone 
secretion and cerebral salt wasting syndrome which could also form major causes of hyponatremia 
in the postoperative period in patients undergoing surgery for pituitary adenomas.  
 
Steroids and incidence of diabetes insipidus 
 
A pituitary adenoma, regardless of the size, rarely causes diabetes insipidus (DI) before 
surgical intervention36.  Hence steroids are capable of unmasking diabetes insipidus in the 
postoperative period in patients undergoing surgery for pituitary adenomas. In our study, there was 
a significant increase in the incidence of diabetes insipidus in patients who received perioperative 
steroids (Group 2),9.09% as compared to the patients in Group 1 who did not receive postoperative 
steroids,3.27% (Table 2). 
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 The preservation of normal adenohypophysis during surgery is the ultimate factor 
determining preservation of the HPA axis.  Hence when the surgeon recognizes that he is not able 
to preserve the adenohypophysis during surgery, postoperative steroids should be given 
irrespective of the immediate postoperative cortisol levels. 
  
  Based on the above data, we identify the incidence of preoperative 
hypocortisolemia to be 19% which would help filter the patients who might benefit from 
withholding steroids. This would also  stem from the use of a reliable definitive test for the 
assessment of the HPA axis preoperatively as the Synacthen test.  This would also avoid labelling 
patients as hypocortisolemic based on the 8 Am serum cotisol alone but who can produce an 
appropriate response to Synacthen test.      
 
  The true incidence of hypocortisolemia from our study was 21% (13 patients) 
including those who had a definite low serum cortisol<3.6 mcg/dl(5 patients) and those 8 patients 
with a cortisol<16 mcg/dl but with hyponatremia or became symptomatic. Hence the remaining 6 
of 19 patients who required steroids postoperatively with hyponatremia could have been evaluated 
for other causes and long term steroids prevented.  We recommend withholding of steroids 
perioperatively in a clinical set up where the patients would be on continous monitoring and 
hypocortisolemia was picked up early and to better give the routine steroid cover for the rest since 
21% patients carried the risk of hypocortisolemia as per our study. 
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  The incidence of hyponatremia in the Groups 1 and 2 were almost similar indicating 
that patients on steroids too can develop hyponatremia due to other causes as SIADH and CSW. 
Hence hypocortisolemia if not strongly considered as the cause of hyponatremia when the serum 
cortisol levels rose to > 16 mcg.dl, evaluation for hyponatremia need to be done to avoid long term 
steroids unnecessarily. 
 
  There has a mean postoperative cortisol surge of 56% in our study with a mean 
positive surge I the 19 patients who required steroids too indicating that further trials need to be 
considered to determine the cut off for the % surge considered appropriate for an intact HPA axis. 
        
HPA axis in the long term 
 
 In our study, in the first follow up visit 3-6 months after the surgery, all 42 patients who 
did not receive perioperative steroid cover remained off steroid supplementation at 3-6 month 
follow up and of the 19 patients who received steroids in study Group 1, 5 did not require steroid 
supplementation at 3-6 month follow up and 6 were continued on steroids while 8 patients lost to 
follow up.  
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CONCLUSION 
 
1) Incidence of preoperative hypocortisolemia- 19% 
2) Preservation of adenohypophysis at surgery was- 100% 
3) Incidence of definite postoperative hypocortisolemia  – 8% (5/61 patients) 
4) Incidence of hyponatremia was 84% 
5) There was a documented 56% surge of cortisol on Day 1 following surgery in the 61 Group 
1 patients with a maximum surge of 111%. 
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SNO
Hospital 
number Age
Gen
der Diagnosis
Hardys
_grade
Date of 
surgery
Preop_co
rtisol8am
Synacth
en 
Done
PostSy
nacthen
cortisol
Apople
xy
Extent of 
excision
hypop
hysis 
preser DI
Postop_
Cortisold
ay1
Postop_
Cortisold
ay2
Postop_
Cortisold
ay3
Cortisolf
ollowup
1 099936F 27 M Non Functional C 21-Feb-12 9.9 Yes 24.85 Yes Radical Yes No 15.15 1.91 5.7 12.79
2 955979D 37 M GH A 21-Jun-11 11.4 Yes 28.69 Yes Radical Yes No 13.44 16.14 7.25 16.08
3 099870F 30 F GH B 12-Jan-12 10.36 Yes 21.08 No Radical Yes No 22.73 10.77 5.34 6.51
4 664565D 53 M Non Functional B 03-Nov-10 20.68 No No Radical Yes No 25.71 4.57 18.82 13.11
5 885104D 50 F Non Functional B 07-Jun-11 20.19 No No Radical Yes No 21.02 6.46 7.06 0
6 193625F 32 M Non Functional C 30-May-12 9.43 Yes 22.52 No Radical Yes No 28.34 17.64 11.3 12.36
7 142723F 39 F GH B 11-Jun-12 11.8 Yes 24.41 No Radical Yes No 30.08 28.05 15.12 11
8 141727F 27 M GH A 16-Mar-12 12.99 Yes 22.81 No Radical Yes No 5.95 21.3 8.19 0
9 812862D 40 F GH A 25-May-11 9.78 Yes 33.88 No Radical Yes No 25.85 5.75 13.1 9.09
10 762194D 44 F GH C 25-Oct-10 6.95 Yes 22.62 No Partial Yes No 25.79 12.76 15.22 12.22
11 271159F 28 F Non Functional B 07-Sep-12 19.81 No No Partial Yes No 16.95 10.93 9.02 18.42
12 087359F 35 M GH micro 02-Mar-12 24.65 No No Radical Yes No 6.4 13.61 12.93 0
13 331910F 34 M Non Functional C 13-Nov-12 7.1 Yes 22.9 Yes Radical Yes No 19.9 9.69 10.25 0
14 964180D 31 F GH B 04-Aug-11 6.88 Yes 23.27 Yes Partial Yes No 13.92 19.59 10.25 18.36
15 977989D 55 M Non Functional C 12-Aug-11 18.23 No No Radical Yes No 28.36 14.44 17.26 12.36
16 019188F 47 F GH B 06-Dec-11 17.03 No No Radical Yes No 13.2 21.37 15.85 0
17 197621F 36 F GH A 20-Jul-12 4.29 Yes 29.26 No Radical Yes No 10.47 14.1 5.6 12.75
18 991943D 29 M GH A 25-Oct-11 6.01 Yes 21.03 No Partial Yes No 13.18 14.53 7.91 11.38
19 926428D 57 M Non Functional C 19-Jul-11 10.81 Yes 24.35 No Partial Yes No 21.88 1.38 7.05
20 056222F 37 F Non Functional C 10-Nov-11 13.78 Yes 23.8 No Partial Yes No 33.2 26.9 20.5 17.49
21 938672D 61 M GH C 22-Jun-11 12.36 Yes 33.06 No Partial No No 14.06 8.68 28.29 8.55
22 165953F 46 F Non Functional C 10-Apr-12 14.21 Yes 25.2 No Radical Yes No 5.58 5.78 10.93 0
23 745702D 50 F GH Micro 15-Nov-10 6.17 Yes 25.02 No Radical Yes No 10.68 5.73 14.49 9.33
24 297575F 61 F Non Functional C 08-Oct-12 16.43 No No Radical Yes No 0 0 0 0
25 052880F 36 F GH C 07-Dec-11 10.4 Yes 24.6 No Radical Yes No 44.02 33.26 18.82 13.13
26 682313D 39 M Non Functional micro 26-Nov-10 5.39 Yes 24.05 No Partial Yes No 26.05 16.49 10.86 0
27 877898D 63 F Non Functional C 11-Feb-11 14.53 Yes 29.9 No Partial Yes No 47.27 31.23 25.45 0
28 884187D 59 M Non Functional B 08-Jun-11 14.09 Yes 26.66 No Radical Yes No 22.96 13.15 9.23 15.23
29 344331F 40 F GH A 13-Dec-12 9.1 Yes 29.02 No Partial Yes No 36.28 16.91 13.95 0
PERIOPERATIVE DATA IN STUDY GROUP 1 (61 Patients)
30 164732F 36 M GH B 07-Aug-12 22.2 No No Partial Yes No 16.94 23.7 23.37 22.96
31 001082F 30 M Non Functional C 30-Aug-11 19.04 No No Radical Yes No 33.9 42.71 23.6 14.05
32 899179D 59 M Non Functional B 13-Jun-11 19.14 No No Radical Yes Yes 12 4.04 0
33 956745D 27 M GH E 27-Jun-11 18.92 No No Partial Yes No 1.88 6.54
34 914364D 55 M Non Functional C 20-Apr-11 17.19 No No Radical Yes No 15.19 6.15 7.5 13.85
35 670599D 47 M GH micro 02-Jun-10 21.4 No No 0 Yes No 17.8 17.9 12.13 13.37
36 088178F 30 M GH A 24-Jan-12 9.63 Yes 27.31 No Partial Yes No 14.32 8.27 8.29 21.67
37 890089D 36 F Non Functional C 10-Mar-11 24.29 No Yes Radical Yes No 17.66 25.32 13.56
38 969191D 29 F GH B 27-Sep-11 9.77 Yes 23.86 No Partial Yes No 14.93 10.8 6.17 11.96
39 007323F 39 M GH E 03-Jan-12 9.72 Yes 24.2 No Partial Yes No 10.1 0 0 12.65
40 258320F 27 M GH A 21-Nov-12 20.1 No No Partial Yes No 30.05 12.91 17.92 19.58
41 992206D 62 M Non Functional B 08-Aug-11 6.37 Yes 29.85 No Partial Yes No 12.28 13.87 9.63 8.05
42 357578B 37 F GH B 21-Nov-11 23.77 No No Radical Yes No 36.4 19.2 19.46 4.55
43 751305D 33 F GH B 19-Oct-10 9.98 Yes 26.17 Yes Partial Yes No 31.63 12.09 9.5 6.28
44 772715D 24 M Non Functional C 16-Dec-10 16.63 No No Partial Yes No 0 0 0 12.48
45 085878F 44 M Non Functional B 27-Jan-12 13.41 Yes 36.1 No Radical Yes No 37.8 23.53 15.6 7.19
46 726302D 29 F GH B 30-Aug-10 21.93 No Yes Partial Yes No 15.95 20.72 21.04 10.16
47 793545D 36 F Non Functional C 20-Oct-10 18.34 No No Partial Yes Yes 28.31 19.58 11.46 9.69
48 175641F 46 F Non Functional C 02-May-12 12.36 Yes 24.4 No Partial Yes No 12.1 4.6 3.26 0
49 355697F 42 M GH A 03-Jan-13 10.24 Yes 28.7 No Radical Yes No 13.9 15.22 12.85 10.81
50 138544F 43 F GH A 23-Mar-12 17.74 No No Radical Yes No 19.29 7.8 6.12 0
51 172765F 46 M Non Functional D 20-Apr-12 11.73 Yes 25.67 No Radical Yes No 43.61 29.6 23.71 12.12
52 795815D 30 F GH C 09-Nov-10 14.59 Yes 20.8 Yes Partial Yes No 17 18.16 18.2 12.53
53 963423D 46 F GH Micro 29-Mar-12 23.29 No No Radical Yes No 41.7 12.01 22.67 10.7
54 763465D 25 F GH C 20-Sep-10 6.8 Yes 23.54 No Radical Yes No 18.16 17.19 15.21 0
55 855540C 26 F GH A 22-Feb-11 36.52 No No Partial Yes No 75 22.94 23.91 12.6
56 799431D 23 F GH B 10-Nov-10 18.42 No Yes Radical Yes No 5.6 13.02 20.62 19.94
57 822299D 45 F Non Functional C 30-Nov-10 13.75 Yes 24.8 No Radical Yes No 23.74 4.5 2.5 0
58 751089D 42 F GH C 16-Sep-10 18 No Yes Partial Yes No 24.8 12.14 12.07 14.86
59 146661C 52 F GH micro 11-Aug-11 9.88 Yes 21.88 No Radical Yes No 14.05 18.73 32.59 13.54
60 874610D 31 M GH A 04-May-12 10.35 Yes 29.42 No Radical Yes No 16.02 22.36 13.1
61 709269D 50 F GH B 28-Jun-10 10.29 Yes 25.97 No Partial Yes No 49.59 25.48 30.58 30.58
SNO
Hospital 
number Age Gender Diagnosis
Hardys_
grade
Date of 
surgery
Preop_cortisol8
am Apoplexy
Extent of 
excision
Diabetes 
insipidus Hyponatremia
Hyponatre
miaday
1 760015D 47 F GH C 03-Dec-10 7.62 No Partial No No
2 005174F 51 M Non Functional B 17-Nov-11 6.97 Yes Partial No Yes 3
3 925277D 55 M Non Functional D 24-Jun-11 0.6 No Partial No No
4 901535C 31 M Non Functional B/E 01-Feb-11 2.72 No Partial Yes No
5 891454D 63 M Non Functional C 14-Apr-11 12.04 No Partial No Yes 11
6 884800D 29 M Non Functional C 10-Jun-11 9.84 No Partial No Yes 7
7 879119D 25 F GH D 25-Feb-11 25.33 No Partial No No
8 857213D 35 M Non Functional B 03-Mar-11 3.37 No Partial No No
9 839927D 24 F GH E 24-May-11 14.08 No Partial No No
10 828220D 56 M Non Functional C 09-Aug-11 2.68 No Partial No No
11 932947D 50 F Non Functional B 06-Aug-11 13.54 No Radical No No
12 781342D 32 M GH D 16-Mar-11 14.62 No Partial No Yes 3
13 935676D 39 M Non Functional C 07-Jun-11 10.8 No Partial No No
14 734903D 37 M GH B 07-Sep-10 6.39 No Radical Yes No
15 671091D 45 M GH micro 09-Sep-10 6.55 No 0 No Yes 7
16 549217C 46 F Non Functional C 24-Nov-11 1.15 No Partial Yes No
17 437590D 47 F Non Functional C 30-Jun-10 14.28 Yes Partial No No
18 071882F 29 M GH B 09-Dec-11 7.12 No Radical No No
19 058446F 63 M Non Functional B 11-Nov-11 8.08 No Radical No Yes 5
20 058312F 31 F GH B 08-Dec-11 4.28 No Partial No No
21 056280F 26 M GH C 05-Dec-11 5.52 Yes Partial No No
22 022366D 57 M GH A 04-Nov-11 4.76 No Radical No No
23 811388D 25 M GH B 16-Feb-11 3.42 Yes Partial No No
24 036786F 44 F Non Functional C 11-Jun-12 0 No 0 No No
25 305276F 41 F GH C 29-Sep-12 16.23 Yes 0 Yes No
26 292428F 36 F Non Functional C 26-Sep-12 2.3 No 0 No No
27 285618F 25 M GH C 27-Sep-12 13.03 No 0 Yes No
28 235139F 32 F GH C 10-Sep-12 4.5 No 0 No No
29 092528C 66 M Non Functional C 04-Sep-12 7.18 Yes 0 No No
30 190054F 34 F Non Functional C 21-Aug-12 4.44 No 0 No No
PERIOPERATIVE DATA FOR GROUP 2 PATIENTS ( 44 PATIENTS)
31 260258F 50 F Non Functional C 14-Aug-12 0 No 0 No No
32 904624D 25 M Non Functional B 24-Jul-12 0 Yes 0 Yes No
33 926022D 48 M Non Functional C 12-Oct-11 12.03 No Radical No Yes 7
34 215440F 23 M Non Functional C 22-Jun-12 10.46 No 0 No No
35 325427F 45 M Non Functional D 15-Nov-12 0.92 No 0 Yes Yes 6
36 183864F 54 M Non Functional C 28-May-12 10.2 No 0 No No
37 162533F 40 F Non Functional C 15-May-12 8.7 No 0 No No
38 186791F 41 M Non Functional C 07-May-12 19.27 Yes 0 Yes No
39 100232F 39 F Non Functional C 15-Mar-12 4.71 No 0 No Yes 1
40 088305F 48 M Non Functional C 05-Jan-12 5.18 No 0 No No
41 984692D 55 M Non Functional C 01-Nov-11 1.5 No Partial Yes No
42 982386D 34 M Non Functional C 18-Aug-11 25.47 No Partial No No
43 967645D 44 F Non Functional C 23-Jun-11 4.8 No Partial No No
44 230682F 35 F GH C 04-Jul-12 9.6 Yes 0 No No
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